Company Overview and News
The online music streaming market is fast growing, thanks to the likes of Apple, Inc. (AAPL - Free Report) , Spotify Technology S.A. (SPOT - Free Report) and Amazon.com, Inc.’s (AMZN - Free Report) Amazon Prime Music that have been playing a key role in reshaping the music industry. According to a recent research by MusicWatch that was provided to Billboard, the number of people paying monthly subscription for music has almost doubled since the end of 2016.
AMZN GOOGL AAPL P LB
Spotify (SPOT) is a Swedish on-demand music streaming giant with the world at its feet. After all, after first bursting onto the scene in 2008, Spotify now rules the industry across the globe.
WFC WFCNP P
Needham analyst Laura Martin on Tuesday raised her Pandora Media Inc. P, +1.18% price target to $13 from $8 on optimism for the company's ability to accelerate subscriber growth and lower its customer acquisition costs. Following meetings with management, she was intrigued by the company's plans to set a minimum price per ad unit, which she believes will help "elongate listening hours" as Pandora is no longer selling the least profitable ad units.
Morgan Stanley analyst Benjamin Swinburne reiterated his neutral view of Pandora Media Inc. P, +2.01% on Monday, following an 84% rise in the company's stock over the past 12 months. "Management has taken some positive operational steps, which has reinforced the expectation for a return to "core" (ex-AdsWizz) ad revenue growth," he wrote, referring to the company's recent acquisition of ad-tech company AdsWizz.
2018-09-04 investorplace - 2
Several recent positive catalysts appear to have transformed Pandora (NYSE:P) stock from a Wall Street dog to a Wall Street darling. Over the last week of August, Pandora stock jumped about 14%, establishing a new 52-week high in the process. The shares, which were trading just over $7 in early May, look to be heading for double digits soon.
SIRI FB T SPOT GOOGL AAPL P GOOG SNAP
2018-09-04 investorplace - 1
To be clear, Raymond James’ analysts made a good point about Pandora Media (NYSE:P) in Wednesday’s updated notes to investors, underscoring the company’s “Strong buy” on not just Pandora stock, but rival Spotify (NYSE:SPOT) as well.
AMZN SPOT AAPL P NFLX SNE
Despite its controversies, Ticketmaster-parent Live Nation Entertainment Inc. has been a winning stock over the past few years. The very things that make the company controversial—high ticket fees and a stronghold on event venues—have helped the company deliver impressive results quarter after quarter.
Investors in Pandora Media, Inc. (P - Free Report) need to pay close attention to the stock based on moves in the options market lately. That is because the Sep 7, 2018 $8 Call had some of the highest implied volatility of all equity options today.
SCVL P BIG PAYC
Pandora Media, Inc. (P - Free Report) was a big mover last session, as the company saw its shares rise more than 5% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $6.74 to $8.20 in the past one-month time frame. The company has seen a mixed track record when it comes to estimate revisions of one increase and eight decreases over the past month, while the Zacks Consensus Estimate has moved lower in the same time period.
SCVL P VNET VNET BIG PAYC
Pandora Media Inc. (P) is breaking out higher following stronger fundamental results. Management has been focusing on making its marketing more efficient, while also using partnerships to expand its audience. The company's balance sheet remains healthy, and with an attractive valuation multiple, as well as upward price momentum, P looks like an intriguing buy at current levels.
SIRI P SNAP
2018-08-23 zacks - 1
Facebook (FB - Free Report) is under considerable pressure from regulatory bodies over the way it deals with fake news and the way customer data is collected and shared through its platform. While fake news/censorship is a more difficult problem to tackle, privacy and security of user data is more within its control.
FB GOOGL TWTR AAPL P NFLX 500570 TATAMOTORS TTM
2017-11-09 - Asif
Pandora is the world’s most powerful music discovery platform, offering a personalized experience for each of its listeners wherever and whenever they want to listen to music—whether through earbuds, car speakers or home audio/video equipment. The company's vision is to be the definitive source of music discovery and enjoyment for billions of users. Pandora is available as an ad-supported service, a radio subscription service called Pandora Plus and an on-demand subscription service called Pandora Premium. The majority of its listener hours occur on mobile devices, with the majority of its revenue generated from advertising on its ad-supported service on these devices. The company offer both local and national advertisers the opportunity to deliver targeted messages to its listeners using a combination of audio, display and video advertisements. The company also generate revenue from subscriptions to Pandora Plus and Pandora Premium. Founded by musicians, Pandora also empowers artists ...
2018-09-18 - Asif
Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...
2018-09-18 - Asif
Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...
2018-09-18 - Asif
Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...
Silicon Investor Message Boards
This table lists all message boards related to P / Pandora Media, Inc. on message board site Silicon Investor.
as of ET